New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
11:22 EDTSBAC, CNQR, ARRY, FENG, JRCCHigh option volume stocks: SBAC FENG CNQR JRCC ARRY
News For SBAC;FENG;CNQR;JRCC;ARRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 18, 2015
07:43 EDTARRYJefferies to hold a conference
Subscribe for More Information
November 16, 2015
09:19 EDTARRYOn The Fly: Pre-market Movers
HIGHER: Nexvet Biopharma (NVET), up 16.8% after NV-01 study meets primary endpoint... Protalix BioTherapeutics (PLX), up 4.8% after announcing that it will conduct a Phase III clinical trial for PRX-102... Array Biopharma (ARRY), up 4.3% after announcing a commercialization collaboration with Pierre Fabre... Perrigo (PRGO), up 2.1% after being upgraded to Buy from Neutral at UBS. DOWN AFTER EARNINGS: Dillard's (DDS), down 11.7% after reporting quarterly results. ALSO LOWER: Clovis Oncology (CLVS), down 71.3% after the FDA requested additional clinical data for rociletinib... KaloBios Pharmaceuticals (KBIO), down 48.9% after announcing that it will wind down its operations... Starwood Hotels (HOT), down 6.3% after announcing that Marriott (MAR) will acquire the company... Marriott is down 2.4%... Five Below (FIVE), down 3.1% after being downgraded to Hold from Buy at Deutsche Bank.
08:19 EDTARRYArray BioPharma to hold a conference call
Management announces Array BioPharma and Pierre Fabre will collaborate to globally develop and commercialize Array's two novel oncology products, Binimetinib and Encorafenib, on a conference call to be held on November 16 at 9 am. Webcast Link
07:36 EDTARRYArray BioPharma and Pierre Fabre announce commercialization collaboration
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use